GlassScriptPhysician profile
Amar Krishna Bhat
NPI 1427443514
$2,603.84
in general payments reported to CMS, 2019-2025
23 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $114 · 2021: $398 · 2022: $617 · 2023: $683 · 2024: $431 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,474.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.60 | 2022-2024 | Alphagan P, Lumigan, Durysta |
| Alcon Vision LLC | $258.14 | 2020-2025 | Clareon, Rocklatan, Argos |
| Mallinckrodt Hospital Products INC. | $207.24 | 2021-2022 | |
| Heidelberg Engineering, INC. | $203.18 | 2024-2025 | Spectralis |
| Novartis Pharmaceuticals Corporation | $173.36 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $140.12 | 2022-2024 | Envista Mx60 Iol, Vyzulta |
| Ocular Therapeutix, INC. | $138.13 | 2023 | Dextenza |
| Oyster Point Pharma, INC. | $118.35 | 2022-2024 | Tyrvaya, Ryzumvi |
| Rxsight INC | $112.71 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Amgen INC. | $99.91 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $99.40 | 2022-2023 | Tepezza |
| Dompe US, INC. | $73.28 | 2021-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.98 | 2020-2021 | |
| Glaukos Corporation | $62.84 | 2021-2023 | |
| Kala Pharmaceuticals, INC. | $62.29 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $50.33 | 2021 | |
| Biotissue Holdings INC. | $49.15 | 2021-2024 | |
| Tearlab Corp | $42.07 | 2022-2023 | Tearlab Osmolarity System |
| Johnson & Johnson Surgical Vision, INC. | $30.71 | 2024 | Tecnis Simplicity |
| Genzyme Corporation | $25.22 | 2024 | |
| Allergan, INC. | $24.60 | 2022 | |
| Sight Sciences, INC. | $16.69 | 2022 | |
| Rayner Intraocular Lenses Limited | $15.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.